AHA today urged the Agency for Healthcare Research and Quality to reconsider its decision to shut down the National Guidelines Clearinghouse. 鈥淭he NGC has been a valuable resource to clinicians and health care organizations in the United States and across the world for two decades,鈥 AHA wrote. 鈥淚t provides easy access to evidence-based guidelines for practice, helping busy clinicians develop plans of care for patients, allowing health care organizations to create standard protocols for practice, embed decision support for their clinicians, and reduce practice variation to ensure the best outcomes for their patients. It is regrettable that budget cuts have forced AHRQ to make the difficult decision to eliminate this valuable resource, much to the detriment of patients and the providers who treat them. We urge you to reconsider this decision.鈥 

Related News Articles

Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride鈥
Headline
The Food and Drug Administration has identified a Class I recall of Q鈥橝pel Medical 072 Aspiration System after the company submitted three device event reports鈥
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue鈥
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at鈥
Headline
As part of the AHA's Patient Safety Initiative, a dedicated webpage features case studies showing how hospitals and health systems across the nation are鈥
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer鈥